Literature DB >> 19438983

Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease.

Ho-Chang Kuo1, Chih-Lu Wang, Chi-Di Liang, Hong-Ren Yu, Chien-Fu Huang, Lin Wang, Kao-Pin Hwang, Kuender D Yang.   

Abstract

Kawasaki disease (KD) is a systemic febrile vasculitis particular coronary artery involvement. Eosinophilia has been found in our and other studies in KD. This study further investigates whether eosinophil-related T helper 2 (Th2) cytokines or the activation marker (eosinophil cationic protein - ECP) is involved in KD with coronary artery lesions (CAL). A total of 95 KD patients were enrolled for this study. Plasma samples were subjected to the measurement of interleukin (IL)-4, IL-5, and eotaxin by Luminex-Bedalyte multiplex beadmates system and to the measurement of ECP by fluoroimmunoassay. Patients with KD had higher eosinophils than controls. Eosinophil-related mediators: IL-4, IL-5, eotaxin, and ECP levels were also higher in KD patients than controls before intravenous immunoglobulin (IVIG) treatment. After IVIG treatment, ECP decreased but IL-4, IL-5, and eotaxin increased significantly. The higher the IL-5 and eosinophil levels after IVIG treatment, the lower rate of CAL was found. Changes of eosinophils after IVIG treatment were positively correlated to changes of IL-5 levels but not ECP levels. An increase of eosinophils and IL-5, but not ECP levels after IVIG treatment, was inversely correlated with CAL formation in KD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19438983     DOI: 10.1111/j.1399-3038.2008.00779.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  52 in total

Review 1.  Genetic polymorphisms in Kawasaki disease.

Authors:  Ho-chang Kuo; Wei-chiao Chang
Journal:  Acta Pharmacol Sin       Date:  2011-09-05       Impact factor: 6.150

2.  Tricuspid regurgitation in acute phase of Kawasaki disease associated with intensive care unit admission.

Authors:  Ying-Jui Lin; I-Chun Lin; Hong-Ren Yu; Hsuan-Chang Kuo; Kuender D Yang; Wei-Chiao Chang; Chi-Di Liang; Shih-Feng Liu; Ho-Chang Kuo
Journal:  Pediatr Cardiol       Date:  2012-07-19       Impact factor: 1.655

3.  Lack of association between ORAI1/CRACM1 gene polymorphisms and Kawasaki disease in the Taiwanese children.

Authors:  Ho-Chang Kuo; Ying-Jui Lin; Suh-Hang Hank Juo; Yu-Wen Hsu; Wei-Chiao Chen; Kuender D Yang; Chi-Di Liang; Shengyu Yang; Mei-Chyn Chao; Hong-Ren Yu; Shouyan Wang; Li-Yan Lin; Wei-Chiao Chang
Journal:  J Clin Immunol       Date:  2011-04-13       Impact factor: 8.317

4.  Association of Attention deficit hyperactivity disorder and Kawasaki disease: a nationwide population-based cohort study.

Authors:  H-C Kuo; W-C Chang; L-J Wang; S-C Li; W-P Chang
Journal:  Epidemiol Psychiatr Sci       Date:  2015-09-22       Impact factor: 6.892

5.  CTLA-4, position 49 A/G polymorphism associated with coronary artery lesions in Kawasaki disease.

Authors:  Ho-Chang Kuo; Chi-Di Liang; Hong-Ren Yu; Chih-Lu Wang; I-Chun Lin; Chieh-An Liu; Jen-Chieh Chang; Chiu-Ping Lee; Wei-Chiao Chang; Kuender D Yang
Journal:  J Clin Immunol       Date:  2010-11-17       Impact factor: 8.317

6.  Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease.

Authors:  Hong-Ren Yu; Ho-Chang Kuo; Eng-Yen Huang; Chi-Di Liang; Kao-Pin Hwang; I-Chun Lin; Jiunn-Ming Sheen; Tzu-Jou Wang; Chih-Lu Wang; Kuender D Yang
Journal:  Pediatr Cardiol       Date:  2010-08-15       Impact factor: 1.655

7.  Effect of breastfeeding for 6 months on disease outcomes in patients with Kawasaki disease.

Authors:  Mindy Ming-Huey Guo; I-Hsin Tsai; Ho-Chang Kuo
Journal:  PLoS One       Date:  2021-12-21       Impact factor: 3.240

8.  Desquamation in Kawasaki Disease.

Authors:  Ling-Sai Chang; Ken-Pen Weng; Jia-Huei Yan; Wan-Shan Lo; Mindy Ming-Huey Guo; Ying-Hsien Huang; Ho-Chang Kuo
Journal:  Children (Basel)       Date:  2021-04-21

9.  Increased Risk of Kawasaki Disease in Infants Born of Mothers With Immune Disorders.

Authors:  Hsiao-Wen Chu; Chien-Heng Lin; Ming-Chih Lin; Ya-Chi Hsu
Journal:  Front Pediatr       Date:  2021-05-14       Impact factor: 3.418

Review 10.  Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease.

Authors:  Lung Chang; Horng-Woei Yang; Tang-Yu Lin; Kuender D Yang
Journal:  Front Pediatr       Date:  2021-07-19       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.